ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 272,32
-0,03%
Dow Jones
42 744,82
-0,22%
DAX
19 848,77
-0,34%
Brent Oil
71,995
-0,99%
Bitcoin
93 580,56
-1,60%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Stevanato Group SpA (STVN)

  7. Stevanato Group SpA (STVN) Actualités

STVN

Stevanato (STVN)

Stevanato Group SpA
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:STVN
DateHeureSourceTitreSymboleSociété
14/11/202422h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
14/11/202421h30Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:STVNStevanato Group SpA
11/11/202412h32Business WireStevanato Group to Present at Upcoming Investor ConferencesNYSE:STVNStevanato Group SpA
05/11/202412h31Business WireStevanato Group Reports Financial Results for the Third Quarter of 2024NYSE:STVNStevanato Group SpA
22/10/202422h30Business WireStevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024NYSE:STVNStevanato Group SpA
01/10/202412h30Business WireStevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI MilanNYSE:STVNStevanato Group SpA
26/09/202413h04Business WireStevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU”NYSE:STVNStevanato Group SpA
04/09/202422h04Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:STVNStevanato Group SpA
06/08/202412h31Business WireStevanato Group Reports Financial Results for the Second Quarter of 2024NYSE:STVNStevanato Group SpA
25/07/202412h30Business WireStevanato Group to Report Second Quarter 2024 Financial Results on August 6, 2024NYSE:STVNStevanato Group SpA
31/05/202422h30Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:STVNStevanato Group SpA
30/05/202411h00Business WireStevanato Group Unveils New Plant in Cisterna di Latina for the Production of Pre-Sterilized EZ-fill® Syringes and CartridgesNYSE:STVNStevanato Group SpA
28/05/202413h00Business WireStevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco MoroNYSE:STVNStevanato Group SpA
24/05/202422h10Business WireStevanato Group Announces Results of Annual General MeetingNYSE:STVNStevanato Group SpA
20/05/202422h37Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:STVNStevanato Group SpA
09/05/202412h39Business WireStevanato Group Reports Financial Results for the First Quarter of 2024NYSE:STVNStevanato Group SpA
01/05/202422h30Business WireStevanato Group to Present at the Bank of America Securities Healthcare ConferenceNYSE:STVNStevanato Group SpA
25/04/202422h04Business WireStevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024NYSE:STVNStevanato Group SpA
04/04/202414h00Business WireStevanato Group appoints Ugo Gay as Chief Operations OfficerNYSE:STVNStevanato Group SpA
26/03/202421h10Business WireStevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary SharesNYSE:STVNStevanato Group SpA
22/03/202404h45Business WireStevanato Group Announces Pricing of Upsized Public Offering of Ordinary SharesNYSE:STVNStevanato Group SpA
20/03/202422h12Business WireStevanato Group Announces Public Offering of Ordinary SharesNYSE:STVNStevanato Group SpA
11/03/202422h05Business WireStevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor ForumNYSE:STVNStevanato Group SpA
07/03/202412h30Business WireStevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023NYSE:STVNStevanato Group SpA
22/02/202422h30Business WireStevanato Group to Report Fourth Quarter and Year End 2023 Financial Results on March 7, 2024NYSE:STVNStevanato Group SpA
24/01/202414h00Business WireStevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and CommercializationNYSE:STVNStevanato Group SpA
03/01/202422h30Business WireStevanato Group to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:STVNStevanato Group SpA
16/11/202312h00Business WireStevanato Group's Mavis™ Combi Visual Inspection Machine Selected as Pharma Innovation Award Winner by Pharma ManufacturingNYSE:STVNStevanato Group SpA
09/11/202312h30Business WireStevanato Group to Present at the Jefferies London Healthcare ConferenceNYSE:STVNStevanato Group SpA
31/10/202311h30Business WireStevanato Group Reports Third Quarter 2023 Financial ResultsNYSE:STVNStevanato Group SpA
 Showing the most relevant articles for your search:NYSE:STVN

Dernières Valeurs Consultées

FTSE
UKX
FTSE 100
COIN
DOGEUSD
Dogecoin
EU
GLE
Societe Generale
EU
BNP
BNP Paribas
EU
ACA
Credit Agricole
EU
CAP
Capgemini
EU
AI
Air Liquide
NASDAQ
MSFT
Microsoft
EU
MC
Lvmh Moet Hennessy Louis...
EU
LR
Legrand
EU
CS
Axa
EU
BN
Danone
USI
USTECH100
US Tech 100
COIN
ETHUSD
Ethereum
EU
ML
Michelin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés